Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E23.62 EPS (ttm)2.59 Insider Own0.08% Shs Outstand1.59B Perf Week2.79%
Market Cap97.49B Forward P/E15.09 EPS next Y4.06 Insider Trans14.76% Shs Float1.57B Perf Month7.69%
Income4.17B PEG2.10 EPS next Q0.77 Inst Own84.50% Short Float7.04% Perf Quarter17.45%
Sales19.26B P/S5.06 EPS this Y-23.10% Inst Trans4.61% Short Ratio7.81 Perf Half Y21.34%
Book/sh3.27 P/B18.71 EPS next Y28.16% ROA14.50% Target Price64.62 Perf Year29.43%
Cash/sh6.43 P/C9.51 EPS next 5Y11.23% ROE92.70% 52W Range44.82 - 61.43 Perf YTD19.59%
Dividend1.96 P/FCF43.79 EPS past 5Y0.00% ROI23.20% 52W High3.08% Beta-
Dividend %3.20% Quick Ratio2.70 Sales past 5Y- Gross Margin76.40% 52W Low41.26% ATR1.63
Employees25000 Current Ratio2.80 Sales Q/Q5.00% Oper. Margin31.20% RSI (14)70.08 Volatility1.90% 2.99%
OptionableYes Debt/Eq2.83 EPS Q/Q3.00% Profit Margin21.70% Rel Volume0.87 Prev Close61.18
ShortableYes LT Debt/Eq2.77 EarningsOct 31 BMO Payout61.80% Avg Volume14.17M Price63.32
Recom2.00 SMA2011.12% SMA5011.47% SMA20020.12% Volume11,463,260 Change3.50%
28-Jul-14Upgrade UBS Neutral → Buy $57 → $67
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
31-Oct-14 02:25PM  AbbVie Beats Q3 Earnings Estimates, Raises Guidance at Investor's Business Daily
01:23PM  AbbVie (ABBV) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
12:08PM  [$$] AbbVie Boosts Earnings Guidance at The Wall Street Journal
11:56AM  Investors Could Triple Their Investments in AbbVie Gurufocus
11:54AM  AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal at The Wall Street Journal
11:22AM  AbbVie says strong results lessen need for big deal Reuters
11:17AM  Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal at Investor's Business Daily
10:20AM  AbbVie Q3 Earnings Top on Humira Sales, Boosts Outlook Zacks
09:30AM  AbbVie hikes forecast, tops Street expectations AP
09:00AM  AbbVie Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:08AM  AbbVie sales blow past forecasts, fueled by Humira Reuters
08:01AM  AbbVie Raises Earnings Guidance After Humira Sales Surge at Bloomberg
08:00AM  AbbVie shares up 2% as profit, sales beat estimates at MarketWatch
07:57AM  AbbVie beats 3Q profit forecasts AP
07:56AM  ABBVIE INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:49AM  AbbVie Reports Third-Quarter 2014 Financial Results PR Newswire
07:07AM  Q3 2014 AbbVie Inc Earnings Release - Before Market Open CCBN
30-Oct-14 03:06PM  What to Watch in the Day Ahead - Friday, Oct. 31 Reuters
29-Oct-14 02:28PM  Will AbbVie (ABBV) Disappoint in this Earnings Season? Zacks
01:59PM  Express Scripts says AbbVie drug could displace Sovaldi on formulary Reuters
09:54AM  U.S. law firm says investigating AbbVie over collapsed Shire deal Reuters
09:51AM  The Zacks Analyst Blog Highlights: AbbVie, Mylan, Abbott Laboratories, Actavis and Mallinckrodt Zacks
08:38AM  If You Purchased Shire plc American Depository Receipts ("ADRs") During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm PR Newswire
28-Oct-14 03:10PM  Pfizer Q3 Earnings Top Estimates Despite Generic Pressure Zacks
02:18PM  Amgen Refuses To Split, But Plans Hearten Investors at Investor's Business Daily
11:46AM  Receptos Soars After Lead Drug Racks Up Another Win at Investor's Business Daily
11:41AM  5 dividend aristocrat stocks set to boost earnings up to 77% at MarketWatch
07:22AM  Pfizer beats forecasts on demand for cancer drugs at CNBC
27-Oct-14 05:04PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
12:17PM  Video: Allergan Lifts Views; Valeant Suggests Higher Bid at Investor's Business Daily
09:50AM  Shire (SHPG) Gains on Q3 Earnings Beat, Ups Guidance Zacks
12:45AM  [$$] Shire Raises Earnings Guidance After Record Sales Growth at The Wall Street Journal
24-Oct-14 10:57PM  [$$] Payout Bonanza at Barrons.com
06:01PM  Shire EPS And Sales Growth Accelerate Investor's Business Daily
05:32PM  Shire's Got Big Plans for AbbVie's Breakup Fee at The Wall Street Journal
03:24PM  Shire CEO on AbbVie collapse & inversions CNBC
12:52PM  Chiquita turns to Brazilian group after Fyffes deal collapses Reuters
11:12AM  Shire EPS Growth Accelerates, Stock Continues Rebound at Investor's Business Daily
07:18AM  Shire Raises Forecast Again After Earnings Beat Estimates at Bloomberg
05:39AM  Goldman's Hedge Fund Selector Highlights 'Extremely Difficult' Period at The Wall Street Journal
23-Oct-14 04:21PM  Brazil suitors increase bid for Chiquita at USA TODAY
08:00AM  AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year PR Newswire
22-Oct-14 04:44PM  Gilead's Hep C Dream Drug Faces Demanding Investors at Investor's Business Daily
12:39PM  AbbVie finally admits it was trying to dodge U.S. taxes at Fortune
09:22AM  Will This Price Target Increase Help AbbVie (ABBV) Stock Today? at TheStreet
06:32AM  AbbVie and HP: corporate writing stinks and the CEO is to blame at Financial Times
21-Oct-14 06:47PM  Celgene Rises 8% In Two Days On Crohn's Disease Drug Data Investor's Business Daily
06:00PM  Making Money With Charles Payne: 10/20/14 at Fox Business
04:46PM  Winners and Losers Emerge In Wake of Treasury's New Tax Rules at The Wall Street Journal
04:20PM  AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend Zacks
02:20PM  AbbVie Inc. -- Moody's: AbbVie shareholder payouts credit negative at Moody's
11:32AM  Video: Celgene Reports More Good Crohn's Drug Data at Investor's Business Daily
11:03AM  AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
10:59AM  RPT-AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
10:58AM  -AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
09:33AM  Chipotle gets smoked; McDonald's sales struggle; Apple gets iPhone pop Hot Stock Minute
09:29AM  Markets open for trading: AbbVie/Shire deal scrapped CNBC
09:14AM  Story Stocks from Briefing.com Briefing.com
07:41AM  [video] AbbVie Officially Scraps Shire Tax Inversion Deal at Bloomberg
06:48AM  Wall Street reacts to big earnings reports; CVS Health's latest move on tobacco; Staples gets hacked Yahoo Finance
06:02AM  ABBVIE INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statements an EDGAR Online
04:59AM  [video] ASOS Profit Falls 14% After Disruptive Fire at Bloomberg
20-Oct-14 09:30PM  AbbVie CEO Gonzalez loses Shire, but wins praise for gusty move Reuters
09:01PM  AbbVie and Shire agree to end $52-billion deal at Los Angeles Times
08:20PM  AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion Benzinga
07:21PM  AbbVie scraps Shire deal, boosts dividend at USA TODAY
07:02PM  AbbVie formally scuttles deal to buy Shire at MarketWatch
06:43PM  Inversion Implosion: AbbVie-Shire Merger Officially Dead at Forbes
06:40PM  [$$] AbbVie, Shire Terminate Deal at The Wall Street Journal
06:27PM  AbbVie to pay Shire $1.64B fee over nixed merger AP
06:26PM  [audio] Newscast: AbbVie and Shire breakup at MarketWatch
06:05PM  AbbVie and Shire Agree to Terminate Their Deal at New York Times
05:59PM  AbbVie hits Treasury as Shire deal dies at Financial Times
05:45PM  Brown & Brown Inc Earnings Call scheduled for 5:45 pm ET today CCBN
05:42PM  AbbVie says $55 billion acquisition of Shire officially dead Reuters
05:40PM  AbbVie, Shire terminate proposed merger, inversion at MarketWatch
05:35PM  AbbVie Ends Purchase of Shire on U.S. Tax Rule Changes at Bloomberg
05:31PM  AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend PR Newswire
05:12PM  Announcement Of Termination Of Proposed AbbVie And Shire Transaction PR Newswire
04:06PM  Taking Stock: Sonenshine, McCracken Agree M&A Between Innings at Bloomberg
03:31PM  Paulsons Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire at New York Times
01:53PM  Top Allergan holder Paulson urges deal with Shire -sources Reuters
01:52PM  Paulson & Co. pushes for Allergan merger with Shire: report at MarketWatch
12:15PM  [video] Report: Paulson pushing Allergan-Shire merger at CNBC
11:33AM  Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked! at TheStreet
11:16AM  Celgene's Crohn's Disease Drug Hits Its Marks at Investor's Business Daily
04:12AM  Pfizer/AZ chase may be off as pharma deals falter at CNBC
01:04AM  IRS Blocks Inversions, So AbbVie Pays $1.64 Billion Kill Fee To Shire...And Deducts It at Forbes
19-Oct-14 01:46PM  Long-term reforms of US tax system required to stop 'deserters' at Financial Times
18-Oct-14 03:04PM  We May Have an Investable Bottom; Smoke Always Clears: Jim Cramer's Best Blogs TheStreet
02:13AM  [$$] Last Week at Barrons.com
01:14AM  [$$] Another Manic Stocktober at Barrons.com
17-Oct-14 05:22PM  Pfizer's AstraZeneca pursuit knocked by Shire deal collapse at Financial Times
04:06PM  Paulsons bet turns sour as AbbVie reconsiders its Shire bid Market Realist
03:30PM  Gilead's Harvoni Receives Notice of Compliance from Canada Zacks
02:23PM  [video] Opinion: Abbvie: The Failed AbbVie Deal Slammed Markets at MarketWatch
12:37PM  Dept. of Irony: AbbVie Can Take Tax Write-Off for Fees On Busted Shire Deal at The Wall Street Journal
09:59AM  Quote of the Week: AbbVie's About Face and Management Credibility at The Wall Street Journal
09:44AM  UPDATE: Bank Of America Reiterates On AbbVie On Move To Standalone Valuation Benzinga
08:35AM  UBSs Big List of Quality Stocks to Buy Now at 24/7 Wall St.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Synthroid to treat hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. It has a strategic collaboration with Infinity Pharmaceuticals, Inc.; and a research and development collaboration with California Life Sciences LLC. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM